|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash Flows from Operating Activities: | |||
| Net (loss) income | |||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||
| Realized gain on marketable securities held in Trust Account | |||
| Excess fair value on transfer of Founder Shares | |||
| Adnin | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Due to related party | |||
| Accounts payable | |||
| Accrued expenses | |||
| Net cash (used in) provided by operating activities | |||
| Cash Flows from Investing Activities: | |||
| Purchase of marketable securities held in Trust Account | |||
| Purchase and reinvestment of marketable securities held in Trust Account | |||
| Proceeds from redemption of marketable securities held in Trust Account | |||
| Net cash provided by investing activities | |||
| Cash Flows from Financing Activities: | |||
| Proceeds from issuance of ordinary shares | |||
| Proceeds from sale of private placement units | |||
| Payment of offering costs | |||
| Payment of promissory note - related party | |||
| Proceeds from promissory note - related party | |||
| Redemptions of Class A ordinary shares subject to redemption | |||
| Net cash (used in) financing activities | |||
| Net Change in Cash and Cash Equivalents | |||
| Cash and Cash Equivalents - Beginning | |||
| Cash and Cash Equivalents - Ending | |||
| Non-Cash Investing and Financing Activities: | |||
| Remeasurement of Class A ordinary shares subject to possible redemption | |||
| Deferred underwriter fee payable |
Loading...
